¥3,064.00
0.92%
Tokyo, Oct 26, 03:18 pm JST. Closed.
ISIN
JP3347200002
Symbol
4507
Index

Shionogi & Stock price

¥3,051.00
+133.00 4.56% 1M
-24.00 0.78% 6M
+210.00 7.39% YTD
+568.00 22.88% 1Y
+772.00 33.87% 3Y
+556.00 22.28% 5Y
+1,294.33 73.68% 10Y
+2,256.00 283.77% 20Y
Tokyo, Closing price Mon, Oct 26 2026
+15.00 0.49%
ISIN
JP3347200002
Symbol
4507
Index
Industry

AI Insights on Shionogi & Insights AI Insights on Shionogi &

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Shionogi & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.

Key metrics

Basic
Market capitalization
¥2.7t
Enterprise Value
¥2.7t
Net debt
¥69.4b
Cash
¥614.8b
Shares outstanding
851.0m
Valuation
P/E
9.8
P/S | estimate
4.7 | 3.7
EV/Sales | estimate
4.9 | 3.8
EV/FCF | ex SBC
15.3 | -
P/B
1.5
Dividends
DPS
¥76.00
Yield 1Y | 5Y
2.5% | 2.5%
Growth 1Y | 5Y
7.0% | 14.7%
Payout 1Y | 3Y
29.5% | 29.6%
Increased
15 Years
Financials
Revenue | estimate
¥563.2b | ¥712.9b
EBITDA
¥220.0b
EBIT
¥198.5b
Net Income
¥263.5b
Free Cash Flow | ex SBC
¥178.6b | -
Growth
Revenue | estimate
27.9% | 42.7%
EBITDA
31.6%
EBIT
21.4%
Net Income
47.1%
Free Cash Flow
1.5%
Margin
Gross
82.1%
EBITDA
39.1%
EBIT
35.3%
Net
46.8%
Free Cash Flow | ex SBC
31.7% | -
Financial Health
Equity Ratio
65.4%
Return on Equity
12.2%
ROCE
10.8%
ROIC
10.4%
Debt/Equity
0.4
More
EPS
¥309.6
FCF per Share
¥209.9
Short interest
-
Employees
5k
Rev per Employee
¥100.8m

Shionogi & Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Shionogi & forecast:

10x Buy
56%
8x Hold
44%

Analyst Opinions

18 Analysts have issued a Shionogi & forecast:

Buy
56%
Hold
44%

Shionogi & Events

Upcoming Event
OCT
29
Q2 2027 Earnings Call
in 3 days
View Past Earnings Reaction

Financial data from Shionogi &

Jun '26
+/-
%
563,206 563,206
28% 28%
100%
- Direct Costs 100,928 100,928
64% 64%
18%
462,278 462,278
22% 22%
82%
- Selling and Administrative Expenses 146,235 146,235
41% 41%
26%
- Research and Development Expense 129,744 129,744
25% 25%
23%
219,976 219,976
32% 32%
39%
- Depreciation and Amortization 21,438 21,438
501% 501%
4%
EBIT (Operating Income) EBIT 198,538 198,538
21% 21%
35%
Net Profit 263,500 263,500
47% 47%
47%

In millions JPY.

Don't miss a Thing! We will send you all news about Shionogi & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Shionogi & Stock News

Neutral
Business Wire
●
5 days ago
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) will present new data at IDWeek 2026 that reinforce the role of Fetroja®/Fetcroja® (cefiderocol), an innovative siderophore cephalosporin, in serious Gram-negative infections. Cefiderocol data highlights at IDWeek will include new U.S. real-world ...
Neutral
Business Wire
●
21 days ago
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that its Board of Directors, at a meeting held on October 5, 2026, approved Shionogi entering into an agreement to acquire IntraBio Inc. (Head Office: Austin, TX; hereinafter “IntraBio”), a biopharmaceutical company developing and commer...
Positive
WSJ
●
21 days ago
The Japanese drugmaker said IntraBio's expertise would strengthen capabilities across its rare disease pipeline.
More Shionogi & News

Company Profile

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Head office Japan
CEO Mr. Teshirogi
Employees 4,955
Founded 1878
Website www.shionogi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today